Heidelberg Pharma AG (ETR:HPHA)
Germany · Delayed Price · Currency is EUR 2.730
-0.100 (-3.53%)
May 8, 2026, 5:35 PM CET
Heidelberg Pharma AG Cash Flow Statement
Financials in millions EUR. Fiscal year is December - November.
Millions EUR. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Net Income | -40.62 | -42.28 | -19.38 | -20.35 | -19.7 | -26.14 |
Depreciation & Amortization | 0.68 | 0.83 | 0.84 | 0.82 | 0.68 | 0.75 |
Other Amortization | 0.02 | 0.02 | 0.04 | 0.05 | 0.08 | 0.06 |
Loss (Gain) From Sale of Assets | 0.02 | 0.01 | 0.06 | 0.07 | -0.01 | 0.01 |
Asset Writedown & Restructuring Costs | 4.97 | 4.97 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | -4.75 | - | - |
Loss (Gain) on Equity Investments | - | - | - | - | - | 0.01 |
Stock-Based Compensation | 0.01 | 0.11 | 0.91 | 0.96 | 0.55 | 0.69 |
Other Operating Activities | 3.26 | 4.59 | -0.06 | -0.12 | -0.33 | 0.46 |
Change in Accounts Receivable | 0.06 | 0.28 | 0.69 | 0.12 | -0.08 | 0.17 |
Change in Inventory | -1.69 | -3.29 | -1.33 | -5.9 | -3.84 | -0.52 |
Change in Accounts Payable | 1.09 | 1.62 | -2.33 | 2.12 | 2.15 | -1.91 |
Change in Unearned Revenue | 0.36 | -1.18 | -4.93 | -4.79 | 10.41 | 0.26 |
Change in Other Net Operating Assets | 2.57 | 2.71 | -4.1 | -1.91 | 1.24 | -0.45 |
Operating Cash Flow | -29.26 | -31.6 | -29.59 | -33.67 | -8.86 | -26.61 |
Capital Expenditures | -0.04 | -0.13 | -0.46 | -0.94 | -0.58 | -1.24 |
Sale of Property, Plant & Equipment | 0.59 | - | 0.03 | 0.03 | 0.02 | - |
Sale (Purchase) of Intangibles | 0.02 | -0.01 | -0.02 | -0.02 | -0.03 | -0.15 |
Investment in Securities | - | - | - | 6.78 | - | -0.01 |
Other Investing Activities | -0 | -0 | - | 0 | - | - |
Investing Cash Flow | 0.57 | -0.14 | -0.45 | 5.85 | -0.6 | -1.4 |
Short-Term Debt Issued | - | - | - | - | 5 | 10 |
Total Debt Issued | - | - | - | - | 5 | 10 |
Short-Term Debt Repaid | - | - | -5 | -10 | - | - |
Long-Term Debt Repaid | - | -0.13 | -0.11 | -0.11 | -0.09 | -0.1 |
Total Debt Repaid | -0.13 | -0.13 | -5.11 | -10.11 | -0.09 | -0.1 |
Net Debt Issued (Repaid) | -0.13 | -0.13 | -5.11 | -10.11 | 4.91 | 9.9 |
Issuance of Common Stock | 18.78 | 18.78 | 22.76 | 0.06 | 79.91 | 20.02 |
Other Financing Activities | -0.3 | -0.3 | -1.58 | -0 | -0.82 | -0.75 |
Financing Cash Flow | 18.34 | 18.35 | 16.08 | -10.05 | 84 | 29.17 |
Foreign Exchange Rate Adjustments | -1.07 | -1.06 | -0.06 | -0.01 | 0.65 | 0 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | - | - |
Net Cash Flow | -11.42 | -14.45 | -14.02 | -37.89 | 75.19 | 1.16 |
Free Cash Flow | -29.31 | -31.73 | -30.04 | -34.61 | -9.45 | -27.85 |
Free Cash Flow Margin | -1105.08% | -2177.08% | -438.64% | -351.07% | -51.03% | -1369.57% |
Free Cash Flow Per Share | -0.62 | -0.68 | -0.65 | -0.74 | -0.25 | -0.86 |
Cash Interest Paid | 0.01 | 0.01 | 0.79 | 0.91 | 0.53 | 0.03 |
Levered Free Cash Flow | -18.42 | -21.74 | -23.51 | -21.5 | -7.26 | -18.84 |
Unlevered Free Cash Flow | -18.41 | -21.74 | -23.42 | -21.02 | -6.74 | -18.53 |
Change in Working Capital | 2.39 | 0.14 | -11.99 | -10.36 | 9.88 | -2.45 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.